1. Challenges for children and adolescents with cancer in Europe: the SIOP-Europe agenda;Vassal;Pediatr Blood Cancer,2014
2. Three-year overall survival for patients with advanced melanoma treated with pembrolizumab in Keynote-001;Robert;J Clin Oncol,2016
3. The SIOPE strategic plan: a European cancer plan for children and adolescents. http://www.SIOPE.eu/SIOPE_StrategicPlan2015/.
4. Règlement (CE) no 1901/2006 du Parlement européen et du conseil du 12 décembre 2006 relatif aux médicaments à usage pédiatrique, modifiant le règlement (CEE) no 1768/92, les directives 2001/20/CE et 2001/83/CE ainsi que le règlement (CE) no 726/2004. http://ec.europa.eu/health/files/eudralex/vol-1/reg_2006_1901/reg_2006_1901_fr.pdf.
5. New drugs for children and adolescents with cancer: the need for novel development pathways;Vassal;Lancet Oncol,2013